Article | August 26, 2016

Key Records Management Considerations During A Life Sciences Merger Or Acquisition

Source: Everteam

Mergers and acquisitions occur regularly. In fact, 30% of world’s largest organizations are considering some merger or acquisition. The life sciences industry, in particular is characterized by frequent merger and acquisition activity. In addition to mergers between large companies –think Pfizer-Allergan – smaller, early stage pharma and biotech companies are often purchased as their R&D efforts yield new drugs ready to go to market.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online